XML 36 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Revenues    
Patent licensing fees $ 4,117,895 $ 7,049,000
Licensed packaging sales 25,274 20,004
Total revenue 4,143,169 7,069,004
Cost of revenues:    
Cost of sales 4,520 3,689
Litigation and licensing expenses 3,383,948 6,071,608
Management support services 2,093 6,774
Selling, general and administrative expenses 1,222,024 957,571
Total operating expenses 4,612,585 7,039,642
Income (loss) from operations (469,416) 29,362
Other expense    
Loss on derivative liability (55,000) (450,000)
Gain on forgiveness of debt 27,628
Interest expense (808,273) (651,088)
Total other expense (835,645) (1,101,088)
Net loss before income tax (1,305,061) (1,071,726)
Income tax (5,234) (1,040,134)
Net loss (1,310,295) (2,111,860)
Net income attributable to non-controlling interest in subsidiary 1,519 1,461
Net Loss Attributable to Quest Patent Research Corporation $ (1,308,776) $ (2,110,399)
Net loss per share - Basic and Diluted $ 0.00 $ (0.01)
Weighted average shares outstanding - Basic and Diluted 383,038,334 383,038,334